Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Latest early clinical blogs

Meet our experts at the following events

Conference

16th Annual World ADC London 2026

February 23 - 26, 2026
Live Events

Certara IQ™ Global Roadshow

Certara IQ™ is going on the road. From APAC to Europe to North America, our experts are bringing hands-on, indepth
Live Events

QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™

Japan: February 26, 2026 – 1:00 – 5:00 pm | Korea: Wednesday, March 4, 2026 – 1:00 – 5:00 pm

All early clinical resources

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Start right, finish strong: Antibody-drug conjugate (ADC) studies for success

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, On-Demand Webinar

Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs)

Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs)

Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Alternative parameters in NCA using Phoenix WinNonlin

Certara Products - Phoenix, Modeling and Simulation - PK/PD, On-Demand Webinar

FAQs: The ICH M15 Guideline and What It Means for Model-Informed Drug Development

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development

Certara Products - Certara IQ, Modeling and Simulation - QSP, On-Demand Webinar

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

Certara Products - Simcyp, Modeling and Simulation - PBPK, On-Demand Webinar

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Certara Products - Phoenix, Modeling and Simulation - PK/PD, On-Demand Webinar

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

QSP in Inflammatory Bowel Disease (IBD): From Biomarkers to Clinical Endpoints, with Virtual Patients

Modeling and Simulation, Modeling and Simulation - QSP, Blog

Why Many Global Drugs Never Reach Japan

Clinical Pharmacology, Drug Development, Press Coverage
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.